Evidence map›Paper›PMID 36732524›Full record

ArticleScientific data2023

Building a knowledge graph to enable precision medicine.

Payal Chandak, Kexin Huang, Marinka Zitnik

Open access · goldAbstract readDataset
In one paragraph

Article in Scientific data, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 172 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed, 1 pooled it
59.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

172 citing papers in PubMed, 1 synthesis or guideline pooled it, 389 citations in OpenAlex.

  1. Pooled it
  2. AI semantics for biomedical data integration.bioRxiv : the preprint server for biology · 2026
    Article
  3. IMF-DDI: Information Mapping and Fusion Framework for Drug-drug Interaction Prediction.Interdisciplinary sciences, computational life sciences · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Causal graph neural networks for healthcare.Nature biomedical engineering · 2026
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. LogosKG: Hardware-Optimized Scalable and Interpretable Knowledge Graph Retrieval.Proceedings of the conference. Association for Computational Linguistics. Meeting · 2026
    Article
  19. Target identification and assessment in the era of AI.Nature reviews. Drug discovery · 2026
    Review
  20. Article

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Payal Chandak *Harvard-MIT Program in Health Sciences and Technology, Cambridge, MA, 02139, USA.ORCID 0000-0003-1097-803X
Kexin Huang *Department of Computer Science, Stanford University, Stanford, CA, 94305, USA.
Marinka ZitnikDepartment of Biomedical Informatics, Harvard Medical School, Harvard University, Boston, MA, 02115, USA. marinka@hms.harvard.edu.ORCID 0000-0001-8530-7228
Broad Institute · USHarvard–MIT Division of Health Sciences and Technology · USStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing personalized diagnostic strategies and targeted treatments requires a deep understanding of disease biology and the ability to dissect the relationship between molecular and genetic factors and their phenotypic consequences. However, such knowledge is fragmented across publications, non-standardized repositories, and evolving ontologies describing various scales of biological organization between genotypes and clinical phenotypes. Here, we present PrimeKG, a multimodal knowledge graph for precision medicine analyses. PrimeKG integrates 20 high-quality resources to describe 17,080 diseases with 4,050,249 relationships representing ten major biological scales, including disease-associated protein perturbations, biological processes and pathways, anatomical and phenotypic scales, and the entire range of approved drugs with their therapeutic action, considerably expanding previous efforts in disease-rooted knowledge graphs. PrimeKG contains an abundance of 'indications', 'contradictions', and 'off-label use' drug-disease edges that lack in other knowledge graphs and can support AI analyses of how drugs affect disease-associated networks. We supplement PrimeKG's graph structure with language descriptions of clinical guidelines to enable multimodal analyses and provide instructions for continual updates of PrimeKG as new data become available.

Indexed as

Pattern Recognition, AutomatedPrecision MedicineHumans

Identifiers

PMID36732524
PMCPMC9893183
OpenAlexW4318983406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.